Date Title Description PDF
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
24 Nov 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 17 November and 23 November 2023 Download
17 Nov 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 10 November and 16 November 2023 Download
10 Nov 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 3 November and 9 November 2023 Download
03 Nov 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 27 October and 2 November 2023 Download
27 Oct 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 20 October and 26 October 2023 Download

Pages

Date Title Description PDF
31 Jan 2020 R&D: new licenses, patents and registered trademarks The Company informs about the commencement of the assessment process to obtain marketing authorisation for Doria® in the European Union Download
08 Jan 2020 Liquidity contracts and specialists Liquidity contract: transactions conducted in the fourth quarter of 2019 Download
20 Dec 2019 Composition of the board of directors The Company informs about the composition of its Board of Directors and its Audit and Appointments and Remuneration Committees. Download
24 Nov 2019 Strategic plans, profit forecasts and presentations The Company releases the presentation related to its strategy update because of the 2019 Investor Day. Download
07 Nov 2019 Information on P&L ROVI releases the press release related to the first nine months 2019 financial results Download

Pages